Pluristem Therapeutics Inc (PSTI)

[Scott999]

I just had a look to see what our primary and secondary outcome measures in our Phase 2 IC. Wanted to see what we can look forward to in April. To my surprise, we only have a primary one only, and here it is.

Log ratio of week 52 maximal walking distance(MWD)to baseline MWD [ Time Frame: 12 months

This is what we are going to see? Could we have been waiting around 5 years and spent a large amount of money on a walk test? I know this is the standard test, as it is the primary measure for most, but surely there has to be some other tests to compare the treatment with. Something a little more scientific, with more conclusive measures. Are they able to report on other things that were not a stated measure? I sure hope so, but not too sure that this could be the case.

Now I looked at many other phase 2'a for comparison. Most had this as their primary outcome. But most had 4 or more others as there secondary outcome. Wouldn't it be better to gain more insight with other measures. Only reason I decided to look into this was from Celularity's trial with the many measures.

Funny the only one I found with one primary and one second that was similar was from Diffusion Pharmaceuticals. A $30 million market cap company. I went through about 15 different ones.

But no, experience means nothing in this industry. On another note, I wouldn't be surprised to see Mark Germain leaving the board. Why would he sell with elections coming up. Hopefully he amd most others do, or at least not get voted back. That includes management.

Let's see some freaking news tomorrow. I'm sick of saying we'll get em next week more than most are tired of seeing it.